PureTech Health PLC (NAS:PRTC)
$ 25.9 -2.4901 (-8.77%) Market Cap: 632.07 Mil Enterprise Value: 414.72 Mil PE Ratio: 0 PB Ratio: 1.41 GF Score: 53/100

PureTech Health PLC at Morgan Stanley Global Healthcare Conference Transcript

Sep 14, 2022 / 06:05PM GMT
Release Date Price: $29.05
Albert Hwang;Morgan Stanley;Managing Director

Good afternoon, everybody. My name is Albert Hwang with Morgan Stanley. Just to read a disclosure quickly. For important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.

So thank you all for coming. I have with me -- Bharatt, maybe you can introduce yourself and give a quick overview of PureTech before we get started with questions.

Bharatt M. Chowrira
PureTech Health plc - President, Secretary, Chief Business Legal & Operating Officer and Executive Director

Okay. So good afternoon, everyone. So my name is Bharatt Chowrira. I'm the President at PureTech. And with me today is Dr. Julie Krop, who's our Chief Medical Officer.

And so we work with PureTech based in Boston, Massachusetts. We are a biopharma company founded on the principle of developing novel medicines based on this idea of validated pharmacology that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot